Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis (Q64720359)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis
clinical trial

    Statements

    PRISTINE (English)
    0 references
    A Randomized, Double-Blind Trial Assessing the Efficacy and Safety of Etanercept 50 mg Twice Weekly and Etanercept 50 mg Once Weekly for the Treatment of Moderate to Severe Psoriasis (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    June 2008
    0 references
    January 2010
    0 references
    273
    0 references
    0 references
    18 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit